InvestorsHub Logo
icon url

celtic

08/28/13 1:47 PM

#7136 RE: MiamiGent #7135

Hey,
I have you on ignore so why am i reading your BS.....
This will probably be deleted. I know you are looking out for us, thanks but no thanks. Now please go save the world someplace else
icon url

KingDMC

08/28/13 1:51 PM

#7138 RE: MiamiGent #7135

Dude why do you keep posting the same garbage?? Please go to another message board. This message board is for true INO shareholders. If people don't want to be here then don't be here but we don't want to keep seeing this garbage you post. Worse than Seeking Alpha
icon url

JJ8

08/28/13 1:52 PM

#7140 RE: MiamiGent #7135

Interesting info, MG. Have no shares. I'm just following it at this time. Thanks.
icon url

ImaPseudonym

08/28/13 1:52 PM

#7141 RE: MiamiGent #7135

INO stock was valued at .66 on 6/24

Then something happened that started a ramp-up in share price. What it could it be.... Oh yeah:


Jul 10, 2013
Inovio's CELLECTRA® Electroporation Delivery Technology Powers Durable, Best-in-Class T-Cell Responses from HIV Vaccine in Human Study
Next-generation HIV vaccine achieves seven-fold increase (7% to 52%) in response rate of CD8 T-cells when delivered with electroporation; robust CD4 or CD8 T-cell responses observed in 89% of subjects



This, and other recent trial data published in peer-reviewed journals was PR'd as it was published and widely disseminated.

After the increase in value (though still not inline with some analysts' targets), shorters moved in to drive the price down.

Now that the supply of available shares to short has become constrained, and we have gone a couple weeks with no major data/announcements, the volume has decreased while the share price gradually works its way back towards the mean analyst price target. Will it continue to slowly work its way back up, retrace to Reasonable's 1.30-1.40 target, or will other news spark a quicker move? Anybody who says they know for sure is, imho, full of it, but I have made my bet.

Just my opninion. Do your own research.